UNIGE document Scientific Article
previous document  unige:9283  next document
add to browser collection
Title

Insulin resistance in HIV protease inhibitor-associated diabetes

Authors
Yarasheski, K. E.
Tebas, P.
Sigmund, C.
Dagogo-Jack, S.
Bohrer, A.
Turk, J.
Cryer, P. E.
show hidden authors show all authors [1 - 9]
Published in Journal of Acquired Immune Deficiency Syndromes. 1999, vol. 21, no. 3, p. 209-216
Abstract BACKGROUND: Fasting hyperglycemia has been associated with HIV protease inhibitor (PI) therapy. OBJECTIVE: To determine whether absolute insulin deficiency or insulin resistance with relative insulin deficiency and an elevated body mass index (BMI) contribute to HIV PI-associated diabetes. DESIGN: Cross-sectional evaluation. PATIENTS: 8 healthy seronegative men, 10 nondiabetic HIV-positive patients naive to PI, 15 nondiabetic HIV-positive patients receiving PI (BMI = 26 kg/m2), 6 nondiabetic HIV-positive patients receiving PI (BMI = 31 kg/m2), and 8 HIV-positive patients with diabetes receiving PI (BMI = 34 kg/m2). All patients on PI received indinavir. MEASUREMENTS: Fasting concentrations of glucoregulatory hormones. Direct effects of indinavir (20 microM) on rat pancreatic beta-cell function in vitro. RESULTS: In hyperglycemic HIV-positive subjects, circulating concentrations of insulin, C-peptide, proinsulin, glucagon, and the proinsulin/insulin ratio were increased when compared with those of the other 4 groups (p <.05). Morning fasting serum cortisol concentrations were not different among the 5 groups. Glutamic acid decarboxylase (GAD) antibody titers were uncommon in all groups. High BMI was not always associated with diabetes. In vitro, indinavir did not inhibit proinsulin to insulin conversion or impair glucose-induced secretion of insulin and C-peptide from rat beta-cells. CONCLUSIONS: The pathogenesis of HIV PI-associated diabetes involves peripheral insulin resistance with insulin deficiency relative to hyperglucagonemia and a high BMI. Pancreatic beta-cell function was not impaired by indinavir. HIV PI-associated diabetes mirrors that of non-insulin-dependent diabetes mellitus and impaired insulin action in the periphery.
Keywords AdultAnimalsAnti-HIV Agents/ adverse effects/therapeutic useC-Peptide/metabolismCells, CulturedCross-Sectional StudiesDiabetes Mellitus, Type 1/ complicationsGlucagon/metabolismHIV Infections/ complications/drug therapyHIV Protease Inhibitors/ adverse effects/therapeutic useHumansIndinavir/ adverse effects/therapeutic useInsulin/metabolismInsulin ResistanceIslets of Langerhans/metabolismMalePhospholipases A/metabolismProinsulin/metabolismRatsRats, Sprague-Dawley
Identifiers
PMID: 10421244
Full text
Structures
Citation
(ISO format)
YARASHESKI, K. E. et al. Insulin resistance in HIV protease inhibitor-associated diabetes. In: Journal of Acquired Immune Deficiency Syndromes, 1999, vol. 21, n° 3, p. 209-216. https://archive-ouverte.unige.ch/unige:9283

210 hits

0 download

Update

Deposited on : 2010-07-12

Export document
Format :
Citation style :